Skip to content

A comparison between 2 videolaryngoscopes, Kingvision and VL3R (Hugemed) in patients posted for electiv surgery under general anaesthesia

A comparative study of Kingvision and VL3R (Hugemed)tm videolaryngoscope for the ease of intubation in adult patients undergoing general anaesthesia for elective surgery - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062678
Enrollment
70
Registered
2024-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intubation using VL3R (Hugemed) Videolaryngoscope: Investigator will pick the envelope with the name of one videolaryngoscope prior to premedication. Patients will be premedicated and p

Sponsors

JNMC hospital, Aligarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Written and well informed consent. 2. ASA grade I-II of either sex. 3. All Mallampatti grades. 4. Age between 18-60 years. 5. Weight between 45-70 Kg.

Exclusion criteria

Exclusion criteria: 1.ASA grade III and IV 2. Previous failed intubations 3. Head and neck surgery 4. Pregnancy 5. Inter incisor distance less than 3 cm 6. Risk of gastric regurgitation ( full stomach, hiatus hernia) 7. Raised ICP or cervical spine injury

Design outcomes

Primary

MeasureTime frame
To compare the time for successful intubation for both the devicesTimepoint: at first capnograph reading

Secondary

MeasureTime frame
Change in haemodynamic parametersTimepoint: pre insertion, immediately post insertion, 3 minutes, 5 minutes, 10 minutes;Ease of intubationTimepoint: At end of intubation

Countries

India

Contacts

Public ContactSyed Kamran Habib

Jawaharlal Nehru Medical College, Aligarh

syedkamranhabib@gmail.com9897172780

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026